Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

105 results about "Lactobacillus johnsonii" patented technology

Lactobacillus johnsonii is a species in the genus Lactobacillus. Its type strain is ATCC 33200. It is part of the healthy vaginal microbiota and has been identified as having probiotic properties.

Lactobacillus johnsonii capable of relieving obesity and application of lactobacillus johnsonii

The invention provides lactobacillus johnsonii capable of relieving obesity and application of the lactobacillus johnsonii, and relates to the technical field of microorganisms and the technical field of biological medicines. The lactobacillus johnsonii LJ-XR25 is separated from excrement of an obesity model mouse treated by gynostemma pentaphyllum essential oil, and the preservation number is GDMCC NO: 65011. The LJ-XR25 provided by the invention can obviously reduce the weight and fat content of an obese mouse model; the traditional Chinese medicine composition has the functions of improving hyperlipidemia symptoms of high-fat diet mice, improving the antioxidant capacity of livers, transporting phospholipids and cholesterol, eliminating cholesterol of peripheral blood vessels and regulating lipid metabolism; meanwhile, the LJ-XR25 can be colonized in the intestinal tract, so that the diversity of intestinal flora is increased, the effect of repairing the intestinal flora disorder caused by high-fat diet is achieved, and the ecological balance of the intestinal tract is restored. The LJ-XR25 provided by the invention can be used for preparing products such as food, medicines, microbial preparations or feed additives for preventing and / or relieving and / or improving and / or treating obesity, and has wide application value and practical significance.
Owner:HENAN UNIV OF CHINESE MEDICINE

Coix seed and radix fici simplicissimae beverage and preparation method thereof

The preparation method comprises the following steps: mixing coix seeds, radix fici simplicissimae, amylase and saccharifying enzyme, performing enzymolysis, sterilizing the obtained enzymolysis mixture, inoculating a complex microbial inoculant for fermentation, performing centrifugal filtration, collecting supernate, and sterilizing to obtain the coix seed and radix fici simplicissimae beverage, the strain in the complex microbial inoculant comprises a combination of lactobacillus plantarum, lactobacillus johnsonii, bifidobacterium animalis and Nerfh growth-promoting lactobacillus. The radix fici simplicissimae and the coix seeds are combined to prepare the composite beverage with good flavor and high antioxidant activity, the flavor expression of the beverage is ensured on the premise that no sweetening agent is additionally added, and in the preparation process, the fermentation is performed through the complex microbial inoculants with specific components, so that the antioxidant activity of the beverage is improved. The four strains are found to have synergistic interaction in the aspects of improving the taste of the beverage and improving the antioxidant activity.
Owner:BRIGHT DAIRY & FOOD CO LTD

Composite sleep-aiding composition based on agilawood and preparation method of composite sleep-aiding composition

The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a composite sleep-aiding composition based on agilawood and a preparation method thereof. The preparation method comprises the following steps: carrying out ultrasonic-assisted enzymolysis on agilawood by adopting amylase and cellulase, carrying out mixed fermentation on the agilawood subjected to enzymolysis by inoculating lactobacillus plantarum, lactobacillus johnsonii and saccharomyces cerevisiae, and carrying out sterilization, filtration, concentration and drying treatment on the fermented agilawood to obtain the agilawood fermentation product. According to the method, the release rate of active substances in the agilawood is increased, the composite sleep-aiding composition containing the agilawood fermentation product has a remarkable sleep-aiding effect, the preparation method is simple, the problem that an existing agilawood product is poor in sleep treatment effect is solved, and the agilawood fermentation product is safe, free of irritation and high in application value.
Owner:GUANGDONG ZHAOXI HEALTH IND INVESTMENT CO LTD

Composition containing kava pepper and mung bean seed extracts, preparation method and application

The invention belongs to the technical field of cosmetic raw materials, and particularly provides a composition containing kava pepper and mung bean seed extracts, a preparation method and application. The preparation method of the mung bean seed extract is specifically optimized, for example, a lactobacillus plantarum strain, a lactobacillus johnsonii strain and a lactobacillus acidophilus strain are compounded and used for fermenting sprouted mung bean liquid, and a fermentation culture medium, fermentation environment conditions and the like are optimized; the nutritional ingredients of protein, glycine, inorganic salt and the like in the prepared mung bean seed extract are effectively improved, so that the prepared composition containing the kava pepper and the mung bean seed extract and the cosmetics thereof can show excellent effects of moisturizing and repairing, resisting inflammation, resisting aging, instantly calming, easing pain and the like.
Owner:广州宾缇生物科技有限公司

Application of probiotics in treatment of primary biliary cholangitis

The invention discloses an application of probiotics in preparation of a medicine for preventing and / or treating cholestatic liver diseases. The probiotics are selected from one or more of plant lactobacillus Lp-G18, bifidobacterium longum subsp. Longum BL-G301, lactobacillus reuteri LR-G100 and lactobacillus johnsonii LJ-G55. Preferably, the cholestatic liver disease is primary biliary cholangitis.
Owner:BIOGROWING CO LTD

Fermentation inoculant for fermenting artemia, fermented artemia and preparation method of fermented artemia

The invention relates to the technical field of fishery breeding baits, and particularly discloses a fermentation inoculant for fermenting artemia, the fermented artemia and a preparation method of the fermented artemia. The fermentation inoculant for fermenting artemia at least comprises a compound of phaffia rhodozyma, lactobacillus johnsonii, lactobacillus rhamnosus and bifidobacterium lactis. The method has the advantage that artemia does not decay for a long time at normal temperature.
Owner:NAFINE CHEMICAL IND GROUP CO LTD YUNCHENG

Microbial agent compounded GABA (gamma-aminobutyric acid) composition and application thereof in promoting growth and development of children

The invention belongs to the field of functional composite microbial preparations, and particularly discloses a microbial agent and GABA compounded composition and application thereof in promoting growth and development of children. The composition is prepared from a freeze-dried bacterial agent and a GABA (gamma-aminobutyric acid) compound, wherein the freeze-dried bacterial agent comprises lactobacillus johnsonii YH1136 and lactobacillus helveticus Helveticus; the GABA compound is prepared by loading GABA with the purity of greater than or equal to 98% on a nano cellulose carrier, and the loading rate is 20-35%. The composition realizes high survival rate of the microbial inoculum and targeted slow release of GABA through a freeze-drying process and enteric coating. Experiments show that the composition can significantly improve the serum GH / IGF-1 level, the bone mineral density and the body growth rate, and has a synergistic effect when combined with the vitamin D3. According to the invention, the problems of single strain function, low GABA utilization rate and gastric acid damage in the prior art are solved, and an efficient and safe solution is provided for children growth and development intervention.
Owner:NANJING LETOP BIOTECHNOLOGY CO LTD

Lactobacillus johnsonii A21065 capable of resisting oxidation, prolonging life and delaying Parkinson's symptom as well as product and application of lactobacillus johnsonii A21065

The invention discloses lactobacillus johnsonii A21065 capable of resisting oxidation, prolonging life and delaying Parkinson's disease as well as a product and application of the lactobacillus johnsonii A21065, and belongs to the technical field of functional strains. The preservation number of the lactobacillus johnsonii A21065 is GDMCC (China General Microbiological Culture Collection Center) No: 65767. In a caenorhabditis elegans model, the lactobacillus johnsonii A21065 shows that the lactobacillus johnsonii A21065 has better effects of improving the oxidation resistance of nematodes, resisting environmental stress and prolonging the life, also shows a good effect in in-vitro experiments of resisting artificial gastrointestinal fluid, resisting cholate and the like, meanwhile, the lactobacillus johnsonii A21065 also has an effect of improving the cognition of a Parkinson nematode model, and the lactobacillus johnsonii A21065 has a good application prospect. The invention has important significance for preventing and / or treating Parkinson's disease.
Owner:AIAGE LIFE SCI CORP LTD

Application of lactobacillus helveticus HH-LPH17 in preparation of medicine for assisting in relieving inflammatory bowel disease

The invention relates to application of lactobacillus helveticus HH-LPH17 in preparation of medicine for assisting in relieving inflammatory bowel diseases and relates to the technical field of probiotic compositions.The probiotic composition for treating the inflammatory bowel diseases comprises, by weight, 10 parts to 80 parts of lactobacillus johnsonii LBJ 456, 10 parts to 60 parts of lactobacillus helveticus HH-LPH17, 10 parts to 60 parts of lactobacillus acidophilus HH-LA26 and 10 parts to 60 parts of bifidobacterium longum HH-BL18. The composition comprises the following components in parts by weight: 10-60 parts of bifidobacterium bifidum HH-BB27 and 10-60 parts of bifidobacterium longum subspecies infantis HH-BI27. According to the probiotic composition for treating the inflammatory bowel disease, probiotic strains with specific effects are screened out, the combination proportion of the probiotic strains is optimized, the probiotic composition for treating the inflammatory bowel disease is prepared, and a novel safe and effective adjuvant therapy method is provided for treatment of the inflammatory bowel disease.
Owner:ZHENGZHOU H&H BIOENGINEERING CO LTD +1

Akk11 strain-containing probiotic agent capable of relieving hyperuricemia, and the use thereof

An Akk11 strain-containing probiotic agent capable of relieving hyperuricemia, and the use thereof. Strains in the probiotic agent include an Akkermansia muciniphila Akk11 strain and a Lactobacillus johnsonii LJ09 strain. It is found in the present application that the two strains possess a potential interaction and can cooperate with each other, thereby synergizing the effect of relieving hyperuricemia, which is specifically manifested in: being capable of remarkably regulating uric acid metabolism and improving renal clearance functions; being capable of effectively inhibiting the activity of a key enzyme for uric acid synthesis so as to reduce the production of uric acid, and being capable of remarkably relieving renal damage and renal dysfunctions associated with high levels of uric acid.
Owner:JIANGSU WECARE BIOTECHNOLOGY CO LTD

Combined probiotics for improving sarcopenia and preparation method and application thereof

The invention discloses combined probiotics for improving sarcopenia as well as a preparation method and application of the combined probiotics, and belongs to the field of probiotics. The invention relates to a combined probiotic for improving sarcopenia. The combined probiotic comprises a lactobacillus reuteri body, a lactobacillus johnsonii body, a lactobacillus fermentum body and a bifidobacterium adolescentis body. The combined probiotics disclosed by the invention can be used for remarkably improving the overall symptoms of sarcopenia model mice, including inhibiting weight loss, constipation symptoms and colonic mucosa destruction, prolonging load swimming time, improving muscle endurance, improving skeletal muscle atrophy, improving the expression of I-type slow muscle fiber protein MyHC I and promoting slow muscle fiber repair, and has the effects of preventing and treating sarcopenia. The invention discloses a probiotic intervention method for treating sarcopenia, which comprises the following steps of: preparing probiotics for treating sarcopenia, reducing the content of inflammatory cytokines in muscular tissues, increasing the content of hepatic glycogen, improving systematic metabolism of mice with sarcopenia and damaged serum markers, including lactic acid, lactic dehydrogenase, creatine kinase, creatinine, alanine transaminase ALT and aspartate transaminase AST, providing a new scheme for probiotic intervention for sarcopenia, and being used for preparing related functional products or intervention means.
Owner:SOUTHERN MEDICAL UNIVERSITY

Probiotic composition for treating rheumatoid arthritis and application thereof

The invention relates to a probiotic composition for treating rheumatoid arthritis and application thereof, and relates to the technical field of probiotic compositions.The probiotic composition for treating rheumatoid arthritis is prepared from, by weight, 10-40 parts of lactobacillus johnsonii LBJ 456, 10-30 parts of lactobacillus helveticus HH-LPH17 and 10-30 parts of lactobacillus acidophilus HH-LA26. The bifidobacterium longum subsp. Longum HH-BL18, the bifidobacterium bifidum HH-BB27 and the bifidobacterium longum subsp. Infantis HH-BI27 are prepared from the following raw materials in parts by weight: 10 to 40 parts of bifidobacterium longum subsp. Probiotic strains with specific effects are screened out, the combination proportion of the probiotic strains is optimized, the probiotic composition for treating rheumatoid arthritis is prepared, and a novel safe and effective adjuvant therapy method is provided for treatment of RA.
Owner:ZHENGZHOU H&H BIOENGINEERING CO LTD

Composition for relieving cough and asthma

The invention discloses a cough and asthma relieving composition, and belongs to the field of traditional Chinese medicines. The cough and asthma relieving composition is prepared from traditional Chinese medicine fermented particles, semen armeniacae amarae, folia perillae acutae and radix peucedani, the traditional Chinese medicine fermented particles are prepared from pericarpium citri reticulatae, radix platycodonis and radix glycyrrhizae as raw materials, cellulase is firstly used for conducting enzymolysis on the raw materials to obtain enzymatic hydrolysate, then lactobacillus plantarum, lactobacillus johnsonii and rhodotorula mucilaginosa are used for conducting mixed fermentation on the enzymatic hydrolysate to obtain fermentation liquor, and the fermentation liquor is prepared into the cough and asthma relieving composition. And sterilizing, filtering, drying and granulating the fermentation liquor to obtain the traditional Chinese medicine fermented granules. The traditional Chinese medicine fermented granules provided by the invention are compounded with the semen armeniacae amarae, the folium perillae and the radix peucedani for use, so that a synergistic effect is achieved, and an excellent cough and asthma relieving effect is achieved.
Owner:GUANGDONG YILI LUODING PHARMA

Molecular markers of lactobacillus johnsonii

PendingCN122303453ANucleotideGenetics
This invention proposes a molecular marker for *Lactobacillus japonicus*, which was deposited on February 7, 2023, at the China General Microbiological Culture Collection Center (CGMCC) with accession number CGMCC No. 26505. The molecular marker comprises a nucleotide sequence selected from one of the following: (1) the nucleotide sequence shown in SEQ ID NO: 24; (2) a nucleotide sequence having at least 97%, 98%, 99%, or higher homology to the nucleotide sequence shown in SEQ ID NO: 24; or (3) a nucleotide sequence having one or more nucleotide substitutions, deletions, or insertions in the nucleotide sequence shown in SEQ ID NO: 24. Using the molecular marker of this invention, not only can the target *Lactobacillus japonicus* be screened quickly and easily, but it can also highly specifically identify the target *Lactobacillus japonicus*, eliminating interference from other strains.
Owner:HANGZHOU GRAND BIOLOGIC PHARMA INC

Anti-fatigue Lactobacillus composition and method of promoting anti-fatigue performance after aerobic exercise of subject in need thereof by using the same

The present disclosure relates to an anti-fatigue Lactobacillus composition. The anti-fatigue Lactobacillus composition, which includes at least one of Lactobacillus brevis GKEX, Lactobacillus plantarum GKK1 and Lactobacillus johnsonii GKJ2 as an active ingredient, administered to a healthy subject for a continuous period of time, can significantly improve fatigue-related biochemical indices and prolong aerobic exercise time to exhaustion, and thus can be used as an active ingredient for preparation of various compositions for anti-fatigue and / or improving athletic ability.
Owner:GRAPE KING BIO LTD

Method of making a fermented plant-based product with a robust taste profile and products thereof

PendingCN122341280ABiotechnologyFermentation
The method includes the steps of providing a plant protein substrate and fermenting the plant protein substrate with a starter culture containing *Lactobacillus johnsonii*. The invention also relates to plant-based products from such fermentation and *Lactobacillus johnsonii* strains suitable for use in the invention. The invention further relates to peptides that impart and / or enhance rich flavors, methods for preparing such peptides, compositions containing such peptides, and the use of such peptides as flavoring agents.
Owner:SOCIETE DES PRODUITS NESTLE SA

A strain of Lactobacillus johnsonii N5 and its application in preventing and treating enteritis and diarrhea

The present invention relates to a strain of Lactobacillus johnsonii N5 and its application in preventing and treating enteritis and diarrhea. Lactobacillus johnsonii N5), was deposited in the China Center for Type Culture Collection on February 10, 2023, with the deposit number CCTCC NO: M2023104. The Lactobacillus johnsonii N5 was isolated from the fecal microorganisms of piglets resistant to heat stress-induced diarrhea. This Lactobacillus johnsonii N5 has the effect of alleviating enteritis and diarrhea, which is specifically reflected in: significantly enhancing the expression of intestinal epithelial tight junction proteins and cytoprotective heat shock protein 70, improving the immune balance of animal intestinal T cells, enhancing immune tolerance, and reducing the degree of intestinal inflammation and the occurrence of diarrheal diseases in animals. Therefore, Lactobacillus johnsonii N5 has a significant effect in preventing and treating diarrhea and related intestinal inflammatory diseases.
Owner:YANGZHOU UNIV

Composition containing probiotics and chlorella and preparation method thereof

The invention relates to the field of probiotic foods, in particular to a composition containing probiotics and chlorella and a preparation method of the composition. The composition is prepared from the following raw materials: lactobacillus rhamnosus, bifidobacterium longum, lactobacillus johnsonii, a chlorella extract, a rhizoma polygonati extract, sugar alcohol, gelatin, chitosan, resistant dextrin and water. The composition prepared by matching compound probiotics lactobacillus rhamnosus, bifidobacterium longum and lactobacillus johnsonii with prebiotics such as a chlorella extract, a rhizoma polygonati extract and sugar alcohol by utilizing gelatin, chitosan and resistant dextrin can be applied to functional food for regulating the intestinal flora structure, so that the problem of imbalance of the intestinal flora is solved.
Owner:SHANXI LINWEI BIOTECHNOLOGY CO LTD

Lactobacillus johnsonii strain od-5, its uses and products

PendingCN122445539AStone formationBacilli
The application discloses a lactobacillus johnsonii OD-5 and application and products thereof, and belongs to the technical field of microorganisms. A technical problem to be solved by the application is to provide a lactobacillus johnsonii capable of treating kidney stones. A technical solution is a lactobacillus johnsonii OD-5 with a preservation number of CGMCC No. 38426. The lactobacillus johnsonii can reduce urine oxalic acid and regulate urine calcium, effectively correct abnormal urine biochemical conditions promoting stone formation, reduce related kidney function damage, and inhibit formation and deposition of calcium oxalate crystals in the kidney at a histopathological level, thereby significantly reducing the stone incidence. The application provides a solid theoretical basis for development of products taking the lactobacillus johnsonii OD-5 as a core component and used for preventing kidney stones and improving stone kidney damage.
Owner:ZHONGKE WISBIOM(BEIJING)BIOTECHNOLOGY CO LTD

Preparation method of anti-inflammatory soothing and repairing microspheres based on trichoderma reesei-lactobacillus johnsonii two-stage fermentation

The invention provides a preparation method of anti-inflammatory soothing and repairing microspheres based on Trichoderma reesei-Lactobacillus johnsonii two-stage fermentation. According to the preparation method, Trichoderma reesei fermentation products, Lactobacillus johnsonii metabolites, specific plant active ingredients and mussel mucoprotein are included. According to the invention, the mussel mucoprotein-trichoderma reesei-lactobacillus johnsonii ternary synergistic anti-inflammatory antibacterial system microspheres are innovatively constructed, the targeted delivery efficiency of active ingredients is remarkably improved through the adhesion characteristic of mussel mucoprotein, and the technical bottlenecks of poor permeability and short action time of a traditional anti-inflammatory preparation are solved. A multi-strain synergistic fermentation process is adopted, beta-glucan secreted by trichoderma reesei and short-chain fatty acid generated by lactobacillus johnsonii generate a synergistic anti-inflammatory effect, and meanwhile, an enzymolysis technology is combined to realize efficient conversion of plant active ingredients, so that the inhibition effect on key inflammatory factors such as TNF-alpha and IL-6 is remarkably enhanced. According to the system, inflammatory pathways such as NF-kappa B and the like are regulated and controlled through multiple targets, the inflammatory reaction is reduced while the growth of pathogenic bacteria is inhibited, a remarkable broad-spectrum antibacterial and anti-inflammatory synergistic effect is shown, and an innovative solution is provided for developing an efficient and safe anti-inflammatory antibacterial preparation.
Owner:GUANGDONG LIYAN BIOTECHNOLOGY CO LTD

Method for rapidly and quantitatively detecting viable bacteria of lactobacillus jensenii in composite viable bacteria medicinal preparation

The invention belongs to the technical field of biology, discloses a method for rapidly and quantitatively detecting viable bacteria of lactobacillus jensenii in a composite viable bacteria medicinal preparation, and particularly discloses a reagent which comprises a primer pair for detecting the lactobacillus jensenii, and the primer pair comprises an upstream primer L.jens-F1 and a downstream primer L.jens-R1. The reagent provided by the invention has good discrimination degree on common strains such as lactobacillus crispatus, lactobacillus reuteri, lactobacillus gasseri, lactobacillus plantarum, lactobacillus fermentum, lactobacillus johnsonii, lactobacillus rhamnosus and lactobacillus delbrueckii in the same genus, and can detect lactobacillus jensenii with high specificity.
Owner:GUANGDONG JUNWEI BIOTECHNOLOGY CO LTD

Application of lactobacillus in the preparation of medicine for preventing and / or treating liver and / or kidney and / or bone damage caused by excessive intake of fluoride

The present invention provides an application of lactobacillus in the preparation of a medicine for preventing and / or treating liver and / or kidney and / or bone damage caused by excessive intake of fluoride, and relates to the technical field of lactobacillus application. The present invention achieves the purpose of preventing and / or treating damage to the liver and / or kidney and / or bone by reducing the accumulation of fluoride in the liver and / or kidney and / or bone, and the lactobacillus is Lactobacillus johnsonii BS15. Lactobacillus johnsonii BS15 is used to reduce the accumulation of fluoride in the body, especially in the liver, kidney and bone during high fluoride exposure, improve the damage to organs caused by high fluoride exposure, promote the excretion of fluoride from the body, promote the excretion of fluoride from the kidney, promote the excretion of fluoride in feces and urine, and improve the damage to the liver, kidney, lung and nerve center of mice. It is safe and effective to use, has no toxic side effects, and has a wider application.
Owner:BEIJING GUOYING ZHILIAN BIOENGINEERING TECHNOLOGY CO LTD

Lactic acid bacteria with hypoglycemic function and application thereof

The present application relates to lactic acid bacteria with blood sugar lowering function and application thereof, and particularly provides a group of lactic acid bacteria with high safety, which can play an important role in regulating intestinal microecological balance of human body and has blood sugar lowering effect.The lactic acid bacteria is named as Lactobacillus johnsonii 4437-4AT, the strain number is 4437-4AT, and was preserved in Guangdong Microbial Culture Collection Center on January 20, 2026, the preservation address is: No. 59 Building, 5th Floor, Guangzhou Xianlie Middle Road 100 Courtyard, the preservation number is: GDMCC NO: 67710.
Owner:NANLING WANZE MICROBIAL ENGINEERING RESEARCH INSTITUTE CO LTD

Broiler feed additive containing chlorella and application thereof

The invention discloses a broiler feed additive containing chlorella and application of the broiler feed additive. The additive contains chlorella; the feed also contains one or more of lactobacillus johnsonii, enterococcus faecalis, saccharomyces cerevisiae and bacillus amyloliquefaciens. By adding the additive disclosed by the invention into daily ration, the intestinal tissue form can be improved by regulating antioxidant and immune functions, so that the growth performance of the broiler chicken can be remarkably improved. In the additive, lactobacillus johnsonii BS15 and enterococcus faecalis YP-2 are combined for use, and saccharomyces cerevisiae WHY-7 and bacillus amyloliquefaciens TL are combined for use, so that the average weight of the broiler chicken is increased, the spleen index after LPS stimulation is reduced, and synergistic interaction is achieved.
Owner:FEED RESEARCH INSTITUTE CHINESE ACADEMY OF AGRICULTURAL SCIENCES

Lactic acid bacteria composition, lactic acid bacteria fermentation liquor, lactic acid bacteria agent, fermented milk and preparation method and application of lactic acid bacteria composition, lactic acid bacteria fermentation liquor and fermented milk

The invention discloses a lactic acid bacteria composition, lactic acid bacteria fermentation liquor, a lactic acid bacteria agent, fermented milk and a preparation method and application thereof, and belongs to the technical field of microorganisms. The lactobacillus composition disclosed by the invention is prepared from lactobacillus johnsonii S2L, lactobacillus reuteri S5L and lactobacillus mucous membrane mucus S16L; the preservation number of the lactobacillus johnsonii S2L is GDMCC No: 66569; the preservation number of the lactobacillus reuteri S5L is GDMCC No: 66558; the preservation number of the lactobacillus mucous membrane S16L is GDMCC No: 66559. The strains in the lactic acid bacteria composition have excellent probiotic characteristics, do not have virulence factors, are fermented in the milk replacer, are short in fermentation time, can improve the protein hydrolysis degree of the milk replacer, reduce the incidence rate of lamb diarrhea and optimize the intestinal microflora, and have positive effects on improving the feed intake of lambs.
Owner:SOUTH CHINA AGRICULTURAL UNIVERSITY

Lactobacillus johnsonii with function of resisting multiple drug-resistant bacterium biofilms and anti-inflammatory activity and application of lactobacillus johnsonii

The invention belongs to the technical field of microorganisms, and particularly relates to lactobacillus johnsonii with a function of resisting multiple drug-resistant bacterium biological membranes and anti-inflammatory activity and application of the lactobacillus johnsonii. The lactobacillus johnsonii A25041 provided by the invention has strong inhibition and anti-biofilm activity on multi-drug-resistant gram-negative bacteria (including escherichia coli, pseudomonas aeruginosa and acinetobacter baumannii) and methicillin-resistant staphylococcus aureus, and the lactobacillus johnsonii A25041 has good acid-base tolerance and gastrointestinal fluid tolerance, so that the lactobacillus johnsonii A25041 can be used for preparing medicines for preventing and treating various diseases. The composition shows excellent anti-inflammatory activity and oxidation resistance, does not have hemolysis capacity, is good in safety, has natural drug resistance to gentamicin, tetracycline, ciprofloxacin, lincomycin and compound sulfamethoxazole, can be used together with antibiotics at the same time or in sequence, maintains intestinal microecological balance and relieves antibiotic burden while exerting the sterilization effect of the antibiotics, and has a good application prospect. The method can be widely applied to functional food development, and has important application value in the field of biological medicine and daily chemical products.
Owner:AIAGE LIFE SCI CORP LTD +3

Anguilla japonica feed composition using fermented pig blood product

PCT designated stage expiredWO2025143624A1BiocideAnimal feeding stuffBiotechnologyWhole blood product
The present invention provides an Anguilla japonica feed composition using a fermented pig blood product, the composition having the effects of promoting the growth of Anguilla japonica, enhancing health, and enhancing feed efficiency. The composition of the present invention comprises a fermented product obtained by inoculating a Lactobacillus johnsonii strain into pig blood and culturing same.
Owner:SAMDA CO LTD

Lactobacillus johnsonii for relieving ulcerative colitis and application thereof

The invention discloses lactobacillus johnsonii for relieving ulcerative colitis and application of the lactobacillus johnsonii, and belongs to the technical field of microorganisms. The lactobacillus johnsonii NSP009 can generate a large amount of indole lactic acid, can improve weight loss and disease activity index increase caused by ulcerative colitis, inhibits colonic atrophy, protects the structural integrity of colonic tissues, reduces the inflammation level in intestinal tracts, and has a good relieving effect on colitis. The lactobacillus johnsonii NSP009 disclosed by the invention is used for preparing a pharmaceutical composition and fermented food for relieving ulcerative colitis, and has a very wide application prospect.
Owner:NANCHANG UNIV

Lactobacillus johnsonii producing novel class iii bacteriocins, engineered bacteria and application thereof

The present application relates to a lactobacillus johnsonii producing a novel class III bacteriocin, an engineered bacterium and application thereof, and belongs to the technical field of microorganisms. Lactobacillus johnsonii The JLJ071 strain of the lactobacillus johnsonii is preserved in the China General Microbiological Culture Collection Center, and the preservation number is CGMCC No.34541. The bacteriocin amino acid sequence is shown in Seq ID No.1. The expressed novel class III bacteriocin has good bactericidal activity on listeria monocytogenes and salmonella pullorum, and has good characteristics such as acid resistance, high temperature resistance and protease resistance, and has a good application prospect in feed additives.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

Lactobacillus composition for slowing ectopic dermatitis

This invention relates to a lactobacillus composition for alleviating atopic dermatitis. This lactobacillus composition comprises at least one of *Lactobacillus johnsonii* strain GKJ2 and *Lactobacillus plantarum* strain GKK1. When administered to subjects suffering from atopic dermatitis for a continuous period, it can regulate Th1, Th2, Treg, and Th17 cellular immunity, alter the intestinal flora, and increase the concentration of short-chain fatty acids in the intestine, thereby alleviating atopic dermatitis. Therefore, this lactobacillus composition can be used as an active ingredient in the preparation of various compositions for alleviating atopic dermatitis.
Owner:GRAPE KING BIO LTD